The patient’s journey
Session 3

Introduction, overview and learning outcomes
Karen Jenkins - UK

Pre-emptive Transplanta-tion/ Living donation
Lisa Burnapp - UK

Transplantation: Immunosuppression and quality of life
Ray Trevitt - UK

Sponsors:
Bristol-Myers Squibb
Roche UK
Syner-med

Renewed Interest in Home Haemodialysis
Tony Goovaerts - Belgium

Dialysis by night saves the day
Menno Kooistra - NL

O 30 Nocturnal dialysis: an alternative to conventional haemodialysis
F Raynaud - France

O 31 Nocturnal Haemodialysis for Children and Adolescents in a Department of Paediatric Nephrology
C Von Puttkamer - Germany

Access: focus on central venous catheter, infection rates, inter fprofessional communication etc.

Facilitators:
Alois Gorke
Waltraud Küntzle

O 32 Reduction in Central Venous Catheter Infection using a Multifaceted Approach
L Oakaby - UK

Preventing and controlling CKD caused by diabetes: does self-management make a difference?
Nicola Thomas - UK

O 34 A systematic approach to training: a needs assessment of peritoneal dialysis-nurses
M Harskamp - NL

O 35 A three-dimensional project: structured management of the new haemodialysis patient
E Slobodsky - Israel

O 36 Implementing a basic education program for haemodialysis nurses
J Cowperthwaite - UK

O 37 Clinical Competencies - who needs them?
K. Taylor - UK

Phosphate control: setting the scene 

Knowledge Quiz

Causes and consequences of hyper-phosphataemia
Hamish Dobbie - UK

Dietary phosphate control: What you need to know
Ione Ashurst - UK  

O 38 Facilitating dietary change in renal disease: investigating patients' perspectives
D Sutton - UK

Sponsor: SHIRE Pharmaceuticals

Break & Poster viewing 4

CONGRESS HALL

MEETING HALL 1

11:00 - 12:00

MEETING HALL 4

MEETING HALL 5

NORTH HALL

The patient’s journey
Session 4

Anaemia in Transplantation
Coral McNichols-Thomas

What happens when you don’t have dialysis?
Karen Jenkins - UK

Conservative management, ­symptom control
Felicity Murtagh - UK

Sponsors:
Bristol-Myers Squibb
Roche UK
Syner-med

Corporate Education Session

Minimising infections in ESRD

Does the way you start dialysis matter?
Dr Peter Rutherford MD, PhD, FRCP
Baxter

Challenges in PD
Speaker to be Confirmed

Challenges in HD
Speaker to be Confirmed

Therapy transfers: what are the risks?
Dr. Watske Smith MD, PhD.
AMC Amsterdam

Comparison of European Methicillin-resistant Staphylococcus Aureus (MRSA) Prevention Strategies and Experiences of Cross-border Cooperation in the Dutch-German Border Area
Robin Koeck - Germany
EUREGIO-MRSA-net (a Network between Germany & Netherlands in the Münsterland) 

MRSA: which activities are efficient?
Alois Gorke - Germany

O 40 Improved hygiene reduces the number of patients with Clostridium Difficile
J Finderup - Denmark

O 41 Back to basics: Banishing the bugs in a busy dialysis unit
J. Moore - UK

Evaluating microcirculation in renal patients
Sylvie Sulková-Dusilová - CZ

O 42 A comparison of two needle insertion techniques in haemodialysis
R Israeli - Israel

O 43 Arterio-Venous Fistula cannulation: Is there a need for change?
J King - UK

O 44 Surgery reports of arterio-venous Fistulas - Dream and Reality
B Spindler - Germany

O 45 Long term use of native arteriovenous fistula (nAVF) and buttonhole technique for all patients: our experience
M Boogaerts - France

Difficulties in achieving phosphate control 

Role of dialysis and medication in phosphate management
Hamish Dobbie - UK

Video
Living with CKD: An European patients' perspective

Practical work: Phosphate management case study
Annemarie Visser - UK

Survey on nutrition therapy approaches to improve nutritional status in RRT
Annemarie Visser - UK  

Sponsor: SHIRE Pharmaceuticals

Lunch Break

MEETING HALL 1

12:30 - 13:30

SATELLITE SYMPOSUM

NORTH HALL

Meet the Education team to discuss Accreditation & Endorsement of Renal Courses for Industry & in Nursing schools and Universities
(Refreshments provided)

CONGRESS HALL

MEETING HALL 1

MEETING HALL 4

MEETING HALL 5

NORTH HALL

Corporate Education Session  

There is Always a Story Behind an Act of Caring: Ensuring Quality & Safety in Dialysis Care

Providing Dialysis Therapy Options: What can and should be removed?
Sudhir Bowry - Germany

Protecting the Patients and Yourself from Infection: It is in your hands!
Joao Fazendeiro - Portugal

Seeing, Reporting and Acting on all Symptoms and Mistakes - Clinical vigilance: avoiding clinical hazards!
Isabel Soley - Spain

Putting Theory into Clinical Practice - Are we really up-to-date?
Cathy Poole - UK

Improving the Patients Well-being: That should be our common commitment!
M.T. Parisotto - Italy

Who we are and where we are going
Jean Yves de Vos - Belgium

Hepatitis C Guidelines
Michel Jadoul - Belgium

Title TBA
Elizabeth Lindley - UK

Session arranged in ­association with KDIGO & the National Kidney Foundation

Modelling the response of patients to ESAs
James Tattersall - UK

O 46 The future of IV iron therapy in CKD patients
P Wilson - UK

O 47 Hematide, a new agent in development for the treatment of CKD anaemia
J Toledo - UK

O 48 Understanding of the Clinical Consequences of Haemoglobin Cycling in CKD Patient with Anaemia
J Ortial - UK

in association with HENNA

ΚΛΑΣΣΙΚΗ ΑΙΜΟΚΑΘΑΡΣΗ
Conventional haemodialysis
κ. ΚΑΤΩΠΟΔΗΣ
K Katopodis 

Αιμοδιήθηση /
on-line αιμοδιήθηση
Haemo-filtration /
on–line haemo-filtration
κ. ΦΑΡΜΑΚΗ ΕΥΑΝΘΙΑ
E Farmaki  

Αιμοδιαδιήθηση /
on-line αιμοδιαδιήθηση
Haemodia-filtration / on–line haemo-diafiltration
κ. ΚΟΚΚΙΝΙΔΗ ΕΙΡΗΝΗ
I Kokkinidi 

Achieving competency in phosphate management 

Providing practical and realistic advice for dietary phosphate restriction
Annemarie Visser - UK

Compliance: How can it be improved ?
Deepa Kariyaswasam - UK 

Practical work: Phosphate management case studies
Annemarie Visser - UK

The future & the Close-up
Hamish Dobbie - UK

Sponsor: SHIRE Pharmaceuticals

Break & Poster viewing 5